Hyunsuk Shim
Overview
Explore the profile of Hyunsuk Shim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
2809
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Huang V, Rejimon A, Reddy K, Trivedi A, Ramesh K, Giuffrida A, et al.
Tomography
. 2023 Mar;
9(2):633-646.
PMID: 36961010
Radiation therapy (RT) is a critical part of definitive therapy for pediatric high-grade glioma (pHGG). RT is designed to treat residual tumor defined on conventional MRI (cMRI), though pHGG lesions...
12.
Ramesh K, Huang V, Rosenthal J, Mellon E, Goryawala M, Barker P, et al.
Tomography
. 2023 Feb;
9(1):362-374.
PMID: 36828381
Glioblastoma (GBM) is a fatal disease, with poor prognosis exacerbated by difficulty in assessing tumor extent with imaging. Spectroscopic MRI (sMRI) is a non-contrast imaging technique measuring endogenous metabolite levels...
13.
Liang Z, Li Y, Huang K, Wagar N, Shim H
Pharm Res
. 2022 Oct;
39(12):3381.
PMID: 36307663
No abstract available.
14.
Liang Z, Bian X, Shim H
Breast Cancer Res Treat
. 2022 Oct;
196(3):665.
PMID: 36273359
No abstract available.
15.
Goryawala M, Mellon E, Shim H, Maudsley A
Neuroradiol J
. 2022 Aug;
36(2):198-205.
PMID: 36000488
Purpose: In this pilot study, DKI measures of diffusivity and kurtosis were compared in active tumor regions and correlated to radiologic response to radiotherapy after completion of 2 weeks of...
16.
Ramesh K, Mellon E, Gurbani S, Weinberg B, Schreibmann E, Sheriff S, et al.
Neurooncol Adv
. 2022 Apr;
4(1):vdac006.
PMID: 35382436
Background: Glioblastomas (GBMs) are aggressive brain tumors despite radiation therapy (RT) to 60 Gy and temozolomide (TMZ). Spectroscopic magnetic resonance imaging (sMRI), which measures levels of specific brain metabolites, can...
17.
Xu K, Ramesh K, Huang V, Gurbani S, Cordova J, Schreibmann E, et al.
Tomography
. 2022 Mar;
8(2):688-700.
PMID: 35314634
Glioblastoma (GBM) is highly aggressive and has a poor prognosis. Belinostat is a histone deacetylase inhibitor with blood-brain barrier permeability, anti-GBM activity, and the potential to enhance chemoradiation. The purpose...
18.
Liang Z, Feng A, Shim H
Cancer Chemother Pharmacol
. 2022 Feb;
89(6):843.
PMID: 35201422
No abstract available.
19.
Zhong J, Huang V, Gurbani S, Ramesh K, Scott Cordova J, Schreibmann E, et al.
J Neurooncol
. 2021 May;
153(2):303-311.
PMID: 33983570
Purpose: MRI is the standard imaging modality used for diagnosis, treatment planning, and post-treatment management of gliomas. Contrast-enhanced T1-weighted (CE-T1w) MRI is used to plan biopsy and radiation for grade...
20.
Weinberg B, Kuruva M, Shim H, Mullins M
Radiol Clin North Am
. 2021 Apr;
59(3):349-362.
PMID: 33926682
Magnetic resonance spectroscopy (MRS) is a valuable tool for imaging brain tumors, primarily as an adjunct to conventional imaging and clinical presentation. MRS is useful in initial diagnosis of brain...